JOANNA KENNEDY: Open Payments
NPI 1871031708 · MIDVALE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,518 in 76 payments from 21 companies in 2025. Trend: 2023 $585 · 2024 $1,108 · 2025 $1,518
Food & beverage: $1,518
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $410 |
| Teva Pharmaceuticals USA, Inc. | 9 | $155 |
| Axsome Therapeutics, Inc. | 2 | $149 |
| Lundbeck LLC | 4 | $96 |
| Neurocrine BioSciences, Inc. | 5 | $89 |
| UCB, Inc. | 3 | $75 |
| Tanabe Pharma America, Inc. | 3 | $61 |
| JAZZ PHARMACEUTICALS INC. | 2 | $55 |
| TG Therapeutics, Inc. | 2 | $52 |
| Grifols USA, LLC | 2 | $49 |
Products named: QULIPTA, AUSTEDO XR, Symbravo, BOTOX, VYEPTI, INGREZZA, Radicava, EPIDIOLEX.
Industry payments across UT — which companies pay providers there.
